About Philips
Creating a

Creating a

healthier future

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Royal Philips is a diversified technology company, focused on improving people’s lives through meaningful innovation. Our health care business makes up 42% of our global sales revenue.

 

With a century of history and more than 450 innovative products and services, we are ready to meet today’s challenges in healthcare by creating solutions that deliver better care to more people at lower cost.

 

Our more than 37,000 employees, working in 100 countries, are committed to helping you create meaningful moments of care, whether in the hospital room, the living room or the boardroom. See how we are working to create a healthier future together.

Meaningful innovation

See a fresh perspective on meaningful innovation driven by insights from patients, clinicians and caregivers.

future of health

Our approach

A fresh perspective on the future of health

We believe that meaningful solutions – those that make a real difference – are developed in partnership with our customers, with an understanding that quality patient care extends outside the hospital walls.

 

Read now

 

Compliance

Delivering meaningful solutions by doing the right thing

By holding ourselves to the highest ethical standards you can focus on what matters most — providing quality care to your patients.

 

Read now

 

meaningful solutions
sustainability image

Sustainability

Acting today to protect tomorrow

From our products to our people, we are committed to leading by example through our environmentally and socially responsible programs.

 

Read now

 

What's trending

News

  • Philips aims to advance cardiac MRI technology through AI-driven research

    Philips aims to advance cardiac MRI technology through AI-driven research

    Click to read more
  • Philips strengthens strategic partnership with Sim&Cure to expand innovation in neurovascular therapy

    Philips strengthens strategic partnership with Sim&Cure to expand innovation in neurovascular therapy

    Click to read more
  • Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology

    Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology

    Click to read more

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.